Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
IMPT-514 by ImmPACT Bio USA for Systemic Lupus Erythematosus: Likelihood of Approval
IMPT-514 is under clinical development by ImmPACT Bio USA and currently in Phase II for Systemic Lupus Erythematosus. According to...
Data Insights
IMPT-514 by ImmPACT Bio USA for Lupus Nephritis: Likelihood of Approval
IMPT-514 is under clinical development by ImmPACT Bio USA and currently in Phase II for Lupus Nephritis. According to GlobalData,...